| Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share of Common Stock |
The
following table sets forth the computation of basic and diluted loss per share of common stock for the three and nine months ended September
30, 2026 and 2025:
Schedule of Computation of Basic and Diluted Earnings (Loss) Per Share of Common Stock
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three
Months Ended
September 30, | | |
Nine
Months Ended
September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Basic
loss per share attributable to common stock: | |
| | | |
| | | |
| | | |
| | |
| Numerator | |
| | | |
| | | |
| | | |
| | |
| Net
loss | |
$ | (666,192 | ) | |
$ | (3,186,832 | ) | |
$ | (6,960,681 | ) | |
$ | (7,257,421 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator | |
| | | |
| | | |
| | | |
| | |
| Weighted
avg. common shares outstanding | |
| 8,244,542 | | |
| 5,413,149 | | |
| 7,757,487 | | |
| 5,371,458 | |
| | |
| | | |
| | | |
| | | |
| | |
| Basic
loss per share attributable to common stock | |
$ | (0.08 | ) | |
$ | (0.59 | ) | |
$ | (0.90 | ) | |
$ | (1.35 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted
loss per share attributable to common stock: | |
| | | |
| | | |
| | | |
| | |
| Numerator | |
| | | |
| | | |
| | | |
| | |
| Net
loss | |
$ | (666,192 | ) | |
$ | (3,186,832 | ) | |
$ | (6,960,681 | ) | |
$ | (7,257,421 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Total
net loss for purpose of calculating diluted net loss per common share | |
$ | (666,192 | ) | |
$ | (3,186,832 | ) | |
$ | (6,960,681 | ) | |
$ | (7,257,421 | ) |
| Denominator | |
| | | |
| | | |
| | | |
| | |
| Weighted
avg. common shares outstanding | |
| 8,244,542 | | |
| 5,413,149 | | |
| 7,757,487 | | |
| 5,371,458 | |
| | |
| | | |
| | | |
| | | |
| | |
| Diluted
loss per share attributable to common stock | |
$ | (0.08 | ) | |
$ | (0.59 | ) | |
$ | (0.90 | ) | |
$ | (1.35 | ) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
The
computation of diluted loss per share for the three and nine months ended September 30, 2026 and 2025 does not include the following
stock options or unvested restricted stock units in the computation of diluted loss per share because these instruments were antidilutive:
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
| | |
Three
Months Ended
September 30, | | |
Nine
Months Ended
September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Stock
options | |
| 480,178 | | |
| 348,497 | | |
| 480,178 | | |
| 348,497 | |
| Unvested
restricted stock units | |
| 15,719 | | |
| 18,137 | | |
| 15,719 | | |
| 18,137 | |
|